1. Introduction {#sec1-marinedrugs-17-00120}
===============

Gorgonians belonging to genus *Briareum* (phylum Cnidaria, family Briareidae) are considered to be a rich source of highly oxygenated diterpenoids, particularly those derived from briarein (briarane) \[[@B1-marinedrugs-17-00120],[@B2-marinedrugs-17-00120],[@B3-marinedrugs-17-00120],[@B4-marinedrugs-17-00120],[@B5-marinedrugs-17-00120],[@B6-marinedrugs-17-00120],[@B7-marinedrugs-17-00120],[@B8-marinedrugs-17-00120],[@B9-marinedrugs-17-00120],[@B10-marinedrugs-17-00120],[@B11-marinedrugs-17-00120]\], eunicellin (cladiellin) \[[@B1-marinedrugs-17-00120],[@B12-marinedrugs-17-00120],[@B13-marinedrugs-17-00120],[@B14-marinedrugs-17-00120],[@B15-marinedrugs-17-00120],[@B16-marinedrugs-17-00120]\], asbestinin \[[@B11-marinedrugs-17-00120],[@B15-marinedrugs-17-00120],[@B17-marinedrugs-17-00120],[@B18-marinedrugs-17-00120],[@B19-marinedrugs-17-00120]\], and, to a lesser extent, cembrane \[[@B20-marinedrugs-17-00120]\]. These metabolites were shown to exhibit various bioactivities such as anti-inflammatory \[[@B2-marinedrugs-17-00120],[@B4-marinedrugs-17-00120],[@B5-marinedrugs-17-00120],[@B13-marinedrugs-17-00120],[@B21-marinedrugs-17-00120]\], analgesic \[[@B22-marinedrugs-17-00120]\], cytotoxic \[[@B7-marinedrugs-17-00120],[@B8-marinedrugs-17-00120],[@B9-marinedrugs-17-00120],[@B10-marinedrugs-17-00120],[@B14-marinedrugs-17-00120],[@B15-marinedrugs-17-00120],[@B23-marinedrugs-17-00120]\], antimalarial \[[@B12-marinedrugs-17-00120],[@B15-marinedrugs-17-00120]\], antiviral \[[@B10-marinedrugs-17-00120],[@B15-marinedrugs-17-00120]\], and antimicrobial \[[@B15-marinedrugs-17-00120]\] activities. Briarellins constitute a class of tetracyclic oxygenated diterpenoids in which an additional seven-membered ether ring (oxepane) is formed between C-3 and C-16 of the eunicellin skeleton. These metabolites were originally discovered from Caribbean gorgonians of genus *Briareum*, e.g., *B. asbestinum* \[[@B13-marinedrugs-17-00120],[@B14-marinedrugs-17-00120],[@B16-marinedrugs-17-00120]\] and *B. polyanthes* \[[@B12-marinedrugs-17-00120],[@B15-marinedrugs-17-00120]\], and also showed interesting bioactivities. Yet, briarellins remain to be isolated from the Pacific *Briareum* genus, although briarellins with the α,β-conjugated enone in the six-membered ring analogs were previously reported from one species of a taxonomically linked *Pachyclavularia* genus \[[@B24-marinedrugs-17-00120],[@B25-marinedrugs-17-00120],[@B26-marinedrugs-17-00120]\]. This prompted us to extensively investigate the chemical constituents of a gorgonian *Briareum violaceum* growing wildly in the Taiwanese waters and to screen their cytotoxic and anti-inflammatory activities. The current study led to the discovery of a group of three new briarellin diterpenoids, briarenones A‒C (**1**‒**3**), characterized by having *cis* fused cyclohexane, cyclodecane, and oxepane rings. The chemical structures of these molecules were resolved by various spectroscopic analyses, including two-dimensional (2D) NMR correlation analysis, while their absolute configurations were assigned by single-crystal X-ray diffraction analysis for **1**.

2. Results and Discussion {#sec2-marinedrugs-17-00120}
=========================

The lyophilized specimen of the gorgonian was extracted with ethyl acetate (EtOAc). The chromatographic fractionation of the solvent-free extract on silica gel and reversed-phase C18 columns and the final separation using reversed-phase high-performance liquid chromatography (RP-HPLC) afforded diterpenoids **1**‒**3** ([Figure 1](#marinedrugs-17-00120-f001){ref-type="fig"}; [Figures S1--S26, Supplementary Materials](#app1-marinedrugs-17-00120){ref-type="app"}).

Briarenone A (**1**) was obtained as a needle crystal, $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ +224.4 (CHCl~3~). Its molecular formula C~22~H~32~O~6~ was determined by the sodium adduct peak \[M + Na\]^+^ at *m/z* 415.2089 in the high-resolution electrospray ionization mass spectrometry (HRESIMS), inferring seven degrees of unsaturation. The infrared (IR) absorption bands at *ν*~max~ 3477, 1728, and 1670 cm^−1^ indicated the presence of hydroxyl, ester carbonyl, and α,β-unsaturated carbonyl functionalities, respectively. As the NMR spectra of **1** showed numerous broad and very weak signals due to the likely presence of a mixture of slowly interconverting conformers on the NMR time scale, remeasuring the spectra at −10 °C allowed us to have better resolution for the signals. The ^1^H NMR spectrum displayed the signals of four methyls, including one olefinic (δ~H~ 1.99 ppm, s), two methyls attached to oxygen-bearing carbons (δ~H~ 1.27 ppm, s and 1.28 ppm, s), and one secondary methyl (δ~H~ 1.09 ppm, d, *J* = 7.2 Hz), signifying the terpenoid nature of **1**. Furthermore, the NMR data ([Table 1](#marinedrugs-17-00120-t001){ref-type="table"}) indicated the existence of an acetyl (δ~C~ 171.3 ppm, δ~C~/δ~H~ 21.5/2.08 ppm) and an α,β-unsaturated ketone (δ~C~ 198.0, 157.0, and δ~C~/δ~H~ 128.0/5.95 ppm). Taking into account the unsaturation degrees mentioned above, the 22 carbon signals in the ^13^C NMR spectrum of **1** ([Table 1](#marinedrugs-17-00120-t001){ref-type="table"}) are, thus, ascribable to the presence of a tetracyclic diterpenoid acetate. Three ring-juncture methines (δ~C~/δ~H~ 51.1/2.71, 48.3/2.5, and 36.8/3.13 ppm), two tetrahydrofuran (THF)-oxymethines (δ~C~/δ~H~ 83.4/3.72 and 77.9/4.79 ppm), and one oxymethylene (δ~C~/δ~H~ 63.7/3.62 and 3.34 ppm) suggested a briarellin-related \[[@B13-marinedrugs-17-00120],[@B16-marinedrugs-17-00120],[@B24-marinedrugs-17-00120],[@B25-marinedrugs-17-00120]\] or an asbestinin-related \[[@B15-marinedrugs-17-00120],[@B17-marinedrugs-17-00120],[@B18-marinedrugs-17-00120]\] structure for **1**. However, since the protons of two methyl groups (δ~H~ 1.99 ppm, s, H~3~-20 and 1.09 ppm, d, *J* = 7.2 Hz, H~3~-17), but not one methyl group, showed *^3^J~CH~* correlations in the heteronuclear multiple bond correlation (HMBC) spectrum with two of the angular methine carbons (δ~C~ 51.1 and 48.3 ppm for C-10 and C-14, respectively), the briarellin-type structure was designated for **1** ([Figure 2](#marinedrugs-17-00120-f002){ref-type="fig"}). Three partial structures were assigned by the analysis of proton correlation spectroscopy (^1^H-^1^H COSY), including that assigned by the allylic correlation of the H~3~-20 (δ~H~ 1.99 ppm) with the olefinic proton H-12 (δ~H~ 5.95 ppm, s) ([Figure 2](#marinedrugs-17-00120-f002){ref-type="fig"}). The connectivity of these partial structures, the positions of the hydroxyl, acetoxyl, and ketone carbonyl, and the ring-fusion carbons of THF and oxepane rings were deduced from the complete correlation analyses of the HMBC spectrum as illustrated in [Figure 2](#marinedrugs-17-00120-f002){ref-type="fig"}. Furthermore, a comparison of the ^13^C NMR data of **1** with those of pachyclavulariaenone F (**4**), isolated from *Pachyclavularia violacea* \[[@B25-marinedrugs-17-00120]\], verified the replacement of the C-4 hydroxymethine group (δ~C~ 69.7 ppm, CH) in **4** by a methylene group (δ~C~ 33.6 ppm, CH~2~) in **1**. This was associated with a significant upfield chemical shift at C-5 (∆δ~C~ ‒8.5 ppm) in **1** relative to that in **4**. The planar structure of **1** was accordingly established ([Figure 2](#marinedrugs-17-00120-f002){ref-type="fig"}). The relative configuration of **1** at C-1, C-2, C-3, C-6, C-7, C-9, C-10, C-14, and C-15, was assigned by the analysis of nuclear rotating-frame Overhauser effect spectroscopy (ROESY) correlations ([Figure 2](#marinedrugs-17-00120-f002){ref-type="fig"}), which were found to be consistent with that of **4** as illustrated in [Figure 2](#marinedrugs-17-00120-f002){ref-type="fig"}. Consequently, two opposite sets of nuclear Overhauser effect (NOE) interactions were observed for **1**. One set displayed NOEs for H-1/H-10, H-1/H-14, H-1/H~3~-17, H-14/H~3~-17, H-1/H-8β (δ~H~ 2.03 ppm, d, *J =* 15.0, 12.0 Hz), and H-8β/H~3~-19, and another set exhibited NOEs for H-2/H~3~-18 and H~3~-18/H-6, while H-9 did not show any NOE correlation with H-10. Thus, H-1, H-10, H-14, H~3~-17, and H~3~-19 should be positioned in the β-face of the molecule, whereas H-2, H-9, H~3~-18, and H-6 should be positioned in its α-face. In order to confirm the molecular structure of **1**, including the absolute configuration, a single-crystal X-ray structure analysis was further performed ([Figure 3](#marinedrugs-17-00120-f003){ref-type="fig"}). The compound was slowly crystallized from MeOH as a monohydrate C~22~H~32~O~6~·H~2~O, with H-bond holding the H~2~O molecule in a hydrophilic pocket. From a dataset collected using copper radiation, the X-ray crystallographic analysis ([Tables S1--S3, Supplementary Materials](#app1-marinedrugs-17-00120){ref-type="app"}) of **1** determined the absolute configurations of briarenone A (**1**) as 1*S*,2*R*,3*R*,6*S*,7*S*,9*R*,10*R*,14*S*,15*S*, which forms a hydrogen bond from 7-OH with a molecule of water.

Briarenone B (**2**) was obtained as a white powder. It possessed a molecular formula of C~20~H~28~O~4~, as established from the sodiated ion peak in the HREIMS (*m/z* 355.1880 \[M + Na\]^+^) of **2**, accounting for seven degrees of unsaturations. The IR absorptions at *ν*~max~ 3420 and 1670 cm^−1^ indicated the presence of hydroxyl and conjugated carbonyl functionalities, respectively. The NMR data of **2**, measured in CDCl~3~ at −10 °C, were comparable to those of the framework of **1** except in the replacement of an *sp^3^* oxycarbon (δ~C~ 74.6 ppm, C, C-7) and a methyl group (δ~C~/δ~H~ 23.7/1.28 ppm, CH~3~, CH~3~-19) in **1** by an exomethylene group (δ~C~/δ~H~ 148.3 ppm, C and 117.7/5.35 and 5.18 ppm, CH~2~, respectively) in **2**. Analysis of NMR data of **2** ([Table 1](#marinedrugs-17-00120-t001){ref-type="table"}) and correlations found in the ^1^H-^1^H COSY and HMBC spectra ([Figure 4](#marinedrugs-17-00120-f004){ref-type="fig"}) enabled the establishment of the gross structure of **2**. Furthermore, the observed NOE correlations for **2** ([Figure 5](#marinedrugs-17-00120-f005){ref-type="fig"}) assigned similar β-positioning for H-1, H-10, H-14, and H~3~-17, and α-orientation for H-2, H-9, and H~3~-18 as found in **1**. Moreover, one of the exomethylene protons (δ~H~ 5.18 ppm, s) exhibited NOE interaction with H-10 (δ~H~ 2.97 ppm, br d, *J* = 7.0 Hz), while the other one (δ~H~ 5.35, s) displayed NOE with the hydroxymethine proton at C-6 (δ~H~ 4.07 ppm, dd, *J* = 11.0, 4.5 Hz). A molecular modeling investigation revealed that H-6 did not exhibit NOE interaction in the nuclear Overhauser effect spectroscopy (NOESY) with the methylene protons at C-8 (distances \>3.7 Å). This designated the α-orientation of 6-OH and, hence, the 6*R* configuration as shown in [Figure 6](#marinedrugs-17-00120-f006){ref-type="fig"}. Moreover, it was found that eunicellins with similar substitutions in the ten-membered ring, but with an 6β-OH ([Figure 6](#marinedrugs-17-00120-f006){ref-type="fig"}), displayed distinctive chemical shifts at C-6 (δ~C~ \< 74.0 ppm), C-7 (δ~C~ ≥ 150.0 ppm), and H-6 (δ~H~ \> 4.25 ppm) \[[@B27-marinedrugs-17-00120],[@B28-marinedrugs-17-00120],[@B29-marinedrugs-17-00120],[@B30-marinedrugs-17-00120]\] than those assigned for **2** (δ 78.3, 148.3, and 4.07 ppm, respectively). This observation also suggests the α-orientation of 6-OH in **2**. On the basis of the above findings, the absolute configuration of **1**, and the biogenetic consideration, the configuration 1*S*, 2*R*,3*R*,6*R*,9*R*,10*R*,14*S*,15*S* was, thus, established for **2**.

The HREIMS (*m*/*z* 355.1880 \[M + Na\]^+^) and NMR data ([Table 1](#marinedrugs-17-00120-t001){ref-type="table"}) indicated a molecular formula C~20~H~28~O~4~ for briarenone C (**3**), inferring that **3** is an isomer of **2**. Therefore, it was found that **3** possessed an α,β-unsaturated carbonyl (IR: *ν*~max~ 1668 cm^−1^ δ~C~ 198.1 ppm, C, 156.4 ppm, C, and δ~C~/δ~H~ 128.6/5.91 ppm, CH) and a hydroxy methine group (IR: *ν*~max~ 3299 cm^−1^; δ~C~/δ~H~ 65.0/4.84 ppm, CH). However, compound **3** differs in the presence of a trisubstituted double bond (δ~C~/δ~H~ 135.4/5.52 ppm, CH and δ~C~ 128.8 ppm, C), instead of a 1,1-disubstituted double bond in **2**, with the appearance of an olefinic methyl (δ~C~/δ~H~ 29.2/1.93 ppm). The hydroxyl group was found to be linked to the allylic carbon (C-5) due to the HMBC correlation observed from the olefinic methyl (δ~H~ 1.93 ppm, H~3~-19) to the *sp^2^* methine carbon (δ~C~ 135.4 ppm, C-6), which in turn exhibited ^1^H-^1^H COSY correlation with H-5 (δ~H~ 4.84 ppm, dd, *J* = 8.5, 8.5 Hz). Moreover, comparison of NMR data of **3** with those of pachyclavulariaenone D pointed out that **3** is the 5-hydroxy isomer of pachyclavulariaenone D \[[@B25-marinedrugs-17-00120]\]. The gross structure of **3** was further elucidated from the full 2D NMR spectroscopic correlation analyses of **3** ([Figure 4](#marinedrugs-17-00120-f004){ref-type="fig"}). The NOE interaction of H~3~-19 with the olefinic methine protons H-6 (δ~H~ 5.52 ppm, d, *J* = 8.5 Hz) ([Figure 5](#marinedrugs-17-00120-f005){ref-type="fig"}), in addition to the downfield shift of C-19 (δ~C~ 29.2 ppm), indicated the *Z* geometry of the 6,7-double bond \[[@B31-marinedrugs-17-00120]\]. Moreover, the NOE correlations for H-2/H~3~-18, H~3~-18/H-5, H-5/H-8α (δ~H~ 2.74 ppm, d, *J* = 14.5 Hz), and H-8α/H-9 disclosed the 5*S* configuration. These NOEs were further validated by a molecular modeling study ([Figure 6](#marinedrugs-17-00120-f006){ref-type="fig"}). Finally, full NOE correlation analysis ([Figure 5](#marinedrugs-17-00120-f005){ref-type="fig"}) coupled with the previous identification of the absolute configuration of **1**, which was co-isolated along with **3**, designated the 1*S*,2*R*,3*R*,5*S*,9*R*,10*R*,14*S*,15*S* configuration for **3**.

Although briarellin-type diterpenoids (e.g., briarellins A--S) were discovered initially from Caribbean gorgonians of genus *Briareum* \[[@B12-marinedrugs-17-00120],[@B13-marinedrugs-17-00120],[@B14-marinedrugs-17-00120],[@B15-marinedrugs-17-00120],[@B16-marinedrugs-17-00120]\], since 1995, numerous related analogs were successfully isolated and identified from *Pachyclavularia violacea* inhabiting Taiwanese \[[@B24-marinedrugs-17-00120],[@B25-marinedrugs-17-00120]\] and Indonesian \[[@B26-marinedrugs-17-00120]\] waters. Unlike the previously identified briarellins, the structures of briarenones A--C (**1**--**3**), isolated in this study from *B. violaceum*, were found to be similar to those of pachyclavulariaenones \[[@B24-marinedrugs-17-00120],[@B25-marinedrugs-17-00120]\] in possessing the three ring-juncture protons (H-1, H-10, and H-14) *cis* to each other and forming the *cis* fusion of the cyclohexane, cyclodecane, and oxepane rings. Also, the determination of the absolute configurations of **1**--**3** by NOE correlation analysis coupled with X-ray crystallographic analysis of **1** using copper radiation, could imply the absolute configurations for similar briarellins isolated from the genera of *Briareum* and *Pachyclavularia*, such as pachyclavulariaenones A--G \[[@B24-marinedrugs-17-00120],[@B25-marinedrugs-17-00120]\], to be similar to that of **1**. Compounds of this kind possessing a six-membered carbocyclic ring *cis*-fused to both of the ten-membered carbocyclic and seven-membered ether rings, making three ring-junction protons (H-1, H-10, and H-14) *cis* to each other, including those reported from *Pachyclavularia violacea* \[[@B24-marinedrugs-17-00120],[@B25-marinedrugs-17-00120],[@B26-marinedrugs-17-00120]\], can be considered as a useful chemotaxonomic marker in classification of gorgonians and in approaching a resolution of the argument for considering the gorgonian species of *Pachyclavularia* to be the same as those of genus *Briareum* \[[@B26-marinedrugs-17-00120],[@B32-marinedrugs-17-00120]\].

The isolated compounds were evaluated against the growth of DLD-1 (human colon adenocarcinoma), HT-29 (human colon carcinoma), and HuCC-T1 (human colon cholangiocellular carcinoma) cell lines. The in vitro anti-inflammatory activities of compounds **1**‒**3** were also measured against the release of elastase and the production of superoxide anions in *N*-formyl-methionyl-leucyl-phenyl-alanine and cytochalasin B (fMLF/CB)-activated neutrophils. However, the compounds did not show either cytotoxic or anti-inflammatory activities in the tested in vitro models.

3. Materials and Methods {#sec3-marinedrugs-17-00120}
========================

3.1. General Experimental Procedures {#sec3dot1-marinedrugs-17-00120}
------------------------------------

Optical rotations and IR spectra were measured on a JASCO P-1020 polarimeter and a JASCO FT/IR-4100 (JASCO Corporation, Tokyo, Japan) spectrophotometer, respectively. HRESIMS spectra were measured on a Bruker APEX II mass spectrometer (Bruker, Bremen, Germany). ^1^H and ^13^C NMR spectra were obtained on a Varian Unity INOVA 600 FT-NMR (or Varian Unity INOVA500 FT-NMR) instruments (Varian Inc., Palo Alto, CA, USA) at 600 MHz (or 500 MHz) for ^1^H, and 150 MHz (or 125 MHz) for ^13^C in CDCl~3~. Thin-layer chromatography (TLC) analyses were performed on precoated silica (Si) gel plates (Kieselgel 60 F-254, 0.2 mm), and Si gel (230--400 mesh) (Merck, Darmstadt, Germany) and C18-reversed phase Si gel (RP-18; 40--63 µM) (Parc-Technologique BLVD, Quebec, Canada) were used for column chromatography. Further purification and the isolation of compounds were performed by reversed-phase high-performance liquid chromatography (RP-HPLC) on a Hitachi L-2455 HPLC apparatus with a Supelco C18 column (250 × 21.2 mm, 5 μm).

3.2. Animal Material {#sec3dot2-marinedrugs-17-00120}
--------------------

The soft coral *B. violaceum* was collected from Jihui Fish Port (Taitung, Taiwan) by scuba divers at a depth of 10--15 m on March 2013 and stored in a freezer at −20 °C until extraction. Moreover, the soft coral was taxonomically identified by Prof. Chang-Feng Dai, National Taiwan University, Taipei. A voucher specimen was deposited in the Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung.

3.3. Extraction and Isolation {#sec3dot3-marinedrugs-17-00120}
-----------------------------

The freeze-dried soft coral (0.5 kg) was extracted with EtOAc (3 × 3 L) and filtered. The filtrate was evaporated in vacuo to yield the EtOAc extract (3.90 g). The extract was fractionated by Si gel column chromatography using EtOAc in *n*-hexane (6.25% to 100%) as a gradient elution system to afford 21 fractions (A01--A21). Fraction A04 was further fractionated on an RP-18 Si gel column, using MeOH-H~2~O (2.5:1) as a mobile phase, into eight subfractions (A0401--A0408). Compound **1** (7.4 mg) was obtained from A405 after two-step purification on RP-HPLC using MeOH-H~2~O (3:2) and acetyl nitrite (CH~3~CN)-H~2~O (1:2). Subfractions A402 and A403 were combined together on the basis of their similar TLC chromatogram and were further separated on RP-HPLC using CH~3~CN-H~2~O (1:2) to yield compounds **2** (4.5 mg) and **3** (2.2 mg).

### 3.3.1. Briarenone A (**1**) {#sec3dot3dot1-marinedrugs-17-00120}

Colorless needles; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ +224.4 (*c* 7.4, CHCl~3~); IR (neat) *ν*~max~ 3477, 2964, 2929, 1728, 1670, and 756 cm^−1^; ^1^H and ^13^C NMR data (600/150 MHz; CDCl~3~), [Table 1](#marinedrugs-17-00120-t001){ref-type="table"}; ESIMS *m/z* 415 \[M + Na\]*^+^*; HRESIMS *m/z* 415.2089 \[M + Na\]^+^ (calculated for C~22~H~32~O~6~Na, *m/z* 415.2091).

### 3.3.2. Briarenone B (**2**) {#sec3dot3dot2-marinedrugs-17-00120}

Colorless powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ −10.7 (*c* 4.5, CHCl~3~); IR (neat) *ν*~max~ 3420, 2912, 2851, 1670, and 772 cm^−1^; ^1^H and ^13^C NMR data (500/125 MHz; CDCl~3~), [Table 1](#marinedrugs-17-00120-t001){ref-type="table"}; ESIMS *m/z* 355 \[M + Na\]^+^; HRESIMS *m/z* 355.1880 \[M + Na\]^+^ (calculated for C~20~H~28~O~4~Na, *m/z* 355.1880).

### 3.3.3. Briarenone C (**3**) {#sec3dot3dot3-marinedrugs-17-00120}

Colorless powder; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ −14.8 (*c* 2.2, CHCl~3~); IR (neat) *ν*~max~ 3299, 2921, 2851, and 1668 cm^−1^; ^1^H and ^13^C NMR data (500/125 MHz; CDCl~3~), [Table 1](#marinedrugs-17-00120-t001){ref-type="table"}; ESIMS *m/z* 355 \[M + Na\]^+^; HRESIMS *m/z* 355.1880 \[M + Na\]^+^ (calculated for C~20~H~28~O~4~Na, *m/z* 355.1880).

### 3.3.4. Single-Crystal X-Ray Crystallography of **1** {#sec3dot3dot4-marinedrugs-17-00120}

A suitable colorless prism of compound **1** was obtained from a solution in MeOH by slow evaporation for a month at 4 °C. The crystal (0.20 × 0.18 × 0.17 mm^3^) was analyzed at 100(2) K, space group *P*2~1~2~1~2~1~ (\# 19). Cell: *a* = 8.3456(3) Å, *b* = 10.6813(3) Å, *c* = 23.4466(8) Å, *V* = 2090.07(12) Å^3^, *Z* = 4, *D*~calcd~ = 1.305 mg/m^3^, and *μ*(CuKα) = 0.790 mm^−1^. Intensity data of single-crystal X-ray diffraction were measured on a Bruker APEX DUO diffractometer. Of the 13326 reflections collected, only 3658 independent reflections \[*R(int)* = 0.0331\] with I \> 2σ(I) were used for the analysis. The structure was solved by direct method and refined by a full-matrix least squares on F2 method. The refinement converged to a final *R~1~* = 0.0401, *wR~2~* = 0.1064, with goodness-of-fit = 1.091. For coordinates corresponding to the absolute stereochemistry represented, absolute structure parameter 0.04(6) was obtained \[[@B33-marinedrugs-17-00120]\].

3.4. Bioassays {#sec3dot4-marinedrugs-17-00120}
--------------

### 3.4.1. Cytotoxicity Assay {#sec3dot4dot1-marinedrugs-17-00120}

Cancer cell (DLD-1, HT-29, and HuCC-T1) lines were purchased from the American Type Culture Collection (ATCC). Compounds **1**‒**3** were evaluated for cytotoxic activity using an Alamar blue assay. Alamar Blue (resazurin) is an important non-toxic redox indicator that is utilized to assess metabolic function and cell health. A complete description of this test was previously described \[[@B34-marinedrugs-17-00120],[@B35-marinedrugs-17-00120]\]. The absorbance was measured at 570 nm using an ELISA plate reader (Thermo Fisher Scientific Instruments Co., Ltd., Vantaa, Finland).

### 3.4.2. In Vitro Anti-Inflammatory Assays {#sec3dot4dot2-marinedrugs-17-00120}

Human neutrophils were obtained from blood by dextran sedimentation, Ficoll-Hypaque centrifugation, and hypotonic lysis and then incubated as previously described \[[@B36-marinedrugs-17-00120]\]. Neutrophils (6 × 10^5^ cells∙mL^−1^) incubated at 37 °C in Hank's balanced salt solution (HBSS) with MeO-Suc-Ala-Ala-Pro-Val-*p*-nitroanilide (100 μM) and Ca^2+^ (1 mM) were treated with dimethyl sulfoxide (DMSO) or the tested compound for 5 min. The activation of neutrophils was challenged for 10 min with fMLF (100 nM)/CB (0.6 and 0.5 μg∙mL^−1^ for superoxide anion generation and elastase release, respectively). The anti-inflammatory activities of compounds **1**‒**3** were measured with examining the inhibition of fLMF/CB-induced human neutrophils producing superoxide anion and elastase, using UV spectrometer detection at wavelengths of 550 nm and 405 nm, respectively \[[@B36-marinedrugs-17-00120],[@B37-marinedrugs-17-00120]\].

4. Conclusions {#sec4-marinedrugs-17-00120}
==============

Three new briarellin type diterpenoids, briarenones A‒C (**1**‒**3**), were identified from *Briareum violaceum* inhabiting Taiwanese waters. The compounds have three *cis* ring-juncture protons (H-1, H-10, and H-14) due to the *cis* fusion of the cyclohexane, cyclodecane, and oxepane rings. The molecular structures of this type may be considered as a useful chemotaxonomic marker in the identification of some species of genus *Briareum*. The absolute configurations of the compounds were assigned on the basis NOE correlation analysis coupled with a single-crystal X-ray diffraction analysis for briarenone A. The isolated metabolites showed no in vitro cytotoxicity against DLD-1, HT-29, and HuCC-T1 cells and did not inhibit the superoxide anion generation or elastase release in fMLF/CB-stimulated neutrophils. Compounds **1**‒**3** did not exhibit cytotoxic and anti-inflammatory activities in this study; however, more biological activity screening should be carried out to discover their pharmaceutical potential. Moreover, the absolute configuration of **1** analyzed by X-ray diffraction would be useful for elucidation of the structurally similar metabolites isolated from the genera *Briareum* and *Pachyclavularia*.
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###### 

The ^1^H and ^13^C NMR chemical shifts for **1**‒**3**.

        1                            2             3                                                                
  ----- ---------------------------- ------------- --------------------------- -------------- --------------------- -------------
  1     3.13 ddd (9.6, 5.4, 4.8)     36.8, CH      3.12 ddd (10.0, 7.0, 4.5)   37.7, CH       2.89 m                40.4, CH
  2     3.72 d (9.6)                 83.4, CH      3.76 d (10.0)               86.4, CH       3.62 d (10.5)         85.8, CH
  3                                  76.5, C                                   75.4, C                              75.5, C
  4α    1.94 br d (10.8)             33.6, CH~2~   1.58 m                      31.6, CH~2~    1.72 d (15.0)         46.4, CH~2~
  4β    1.49 m                                     1.58 m                                     2.36 dd (14.5, 8.5)   
  5α    1.94 br d (10.8)             27.2, CH~2~   2.04 m                      28.7, CH~2~    4.84 dd (8.5, 8.5)    65.0, CH
  5β    1.58 ddd (11.4, 10.8, 3.6)                 1.79 m                                                           
  6     5.77 dd (11.4, 3.6)          78.0, CH      4.07 dd (11.0, 4.5)         78.3, CH       5.52 d (8.5)          135.4, CH
  7                                  74.6, C                                   148.3, C                             128.8, C
  8α    1.81 dd (15.0, 3.6)          45.5, CH~2~   2.77 dd (14.0,4.5)          37.0, CH~2~    2.74 d (14.5)         38.6, CH~2~
  8β    2.03 dd (15.0, 12.0)                       2.14 dd (14.0,5.0)                         2.01 dd (14.5, 3.5)   
  9     4.79 dd (12.0, 3.6)          77.9, CH      4.45 dd (5.0, 4.0)          82.2, CH       4.29 dd (6.5, 3.0)    81.2, CH
  10    2.71 br d (6.0)              51.1, CH      2.97 br d (7.0)             50.3, CH       2.82 br d (8.5)       48.3, CH
  11                                 157.0, C                                  156.6, C                             156.4, C
  12    5.95 s                       128.0, CH     5.93 s                      127.4, CH      5.91 s                128.6, CH
  13                                 198.1, C                                  198.1, C                             198.1, C
  14    2.50 br d (4.8)              48.3, CH      2.42 br d (4.5)             48.5, CH       2.31 dd (4.5, 5.5)    48.4, CH
  15    2.67 m                       30.0, CH      2.59 m                      30.4, CH       2.58 m                32.3, CH
  16α   3.62 d (13.8)                63.8, CH~2~   3.35 dd (13.5,3.5)          63.9, CH~2~    3.52 m                65.2, CH~2~
  16β   3.34 br d (13.8)                           3.54 d (13.0)                              3.52 m                
  17    1.09 d (7.2)                 17.2, CH~3~   1.04 d (7.5)                17.2, CH~3~    1.02 d (7.5)          18.5, CH~3~
  18    1.27 s                       22.2, CH~3~   1.25 s                      23.8, CH~3~    1.41 s                27.5, CH~3~
  19    1.28 s                       23.7, CH~3~   5.35 s; 5.18 s              117.7, CH~2~   1.93 s                29.2, CH~3~
  20    1.99 s                       21.9, CH~3~   1.98 s                      21.8, CH~3~    1.91 s                21.9, CH~3~
  Ac    2.08 s                       21.5, CH~3~                                                                    
                                     171.3, C                                                                       

*^a^* Spectra recorded at 600 MHz in CDCl~3~ at −10 °C; *^b^* spectra recorded at 150 MHz in CDCl~3~ at −10 °C; *^c^* spectra recorded at 500 MHz in CDCl~3~; *^d^* spectra recorded at 125 MHz in CDCl~3~.
